ReviewInternational journal of molecular sciences2022

CRISPR/Cas: A New Tool in the Research of Telomeres and Telomerase as Well as a Novel Form of Cancer Therapy.

Mahendar Porika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.